Further experiments should be conducted to validate the correlation between RAB32 expression and immune infiltration, as well as to investigate whether immunotherapy can effectively inhibit RAB32 expression to improve the prognosis of glioma patients. Here, RAB32 is linked to central nervous system cancer.